NCT03260790View on ClinicalTrials.gov

Pneumococcal Vaccines in Patients With Asthma

PHASE4CompletedINTERVENTIONAL
Enrollment

17

Participants

Timeline

Start Date

October 1, 2017

Primary Completion Date

December 21, 2020

Study Completion Date

December 25, 2020

Conditions
Asthma
Interventions
BIOLOGICAL

PCV13

Single 0.5 ml dose of PCV13 administered via intramuscular injection

BIOLOGICAL

PPSV23

Single 0.5 ml dose of PPSV23 administered via intramuscularly or subcutaneously

Trial Locations (1)

55905

Mayo Clinic in Rochester, Rochester

Sponsors

Lead Sponsor

Mayo Clinic
All Listed Sponsors
lead

Mayo Clinic

OTHER

NCT03260790 - Pneumococcal Vaccines in Patients With Asthma | Biotech Hunter | Biotech Hunter